Assignee

Epizyme, Inc.

Patents = 158

Trademarks = 7

Forward Citations = 2,285

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

108 inventors (with patents filed for the assignee):

Epizyme, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel epigenetic therapies for cancer and other serious diseases. Epizyme's proprietary platform enables the identification and development of small molecule inhibitors of chromatin modifying proteins (CMPs), which regulate gene expression. The company aims to improve patient outcomes by targeting the underlying genetic abnormalities driving diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com